Caribbean Air Force

Early Warning Signs of Heart Failure May Appear Years Before Diagnosis, Says Mayo Clinic Cardiologist

EDITORIAL REVIEW REQUIRED — EXPRESS DRAFT. This is an unpublished draft. Some claims may be unconfirmed. Check dates, sources, claims, photographs, and video rights before publishing.

A Panama-born cardiologist at Mayo Clinic in Jacksonville, Florida is drawing attention to the importance of recognizing heart disease before patients experience the familiar symptoms of breathlessness, swollen feet, and reduced ability to perform daily activities. Speaking to Caribbean and Latin American journalists, Dr. José Nativi Nicolau emphasized that one of the most significant developments in modern cardiology is the growing ability to identify patients at risk before conventional symptoms appear.

Dr. Nicolau’s research focuses on cardiac amyloidosis, a condition where abnormal protein deposits accumulate in organs and tissues. He explained that transthyretin amyloidosis occurs when a protein normally produced by the liver becomes deposited throughout the body, affecting joints, the nervous system, and the heart. This means that seemingly unrelated symptoms—such as carpal tunnel syndrome affecting both wrists, persistent back pain, spinal stenosis, and peripheral neuropathy—may actually be manifestations of the same underlying disease. Historically, patients have moved between different specialists investigating these symptoms separately, without anyone connecting them to a common cause.

Advances in diagnostic technology are making detection easier. Previously, a heart biopsy was often required to confirm cardiac amyloidosis, but newer imaging techniques such as pyrophosphate scanning now allow doctors to establish the diagnosis without routine invasive procedures. Additionally, artificial intelligence is enhancing electrocardiograms by analyzing them against databases containing millions of recordings, identifying patterns that could indicate conditions otherwise undetected. However, Dr. Nicolau cautioned that AI is not a substitute for medical assessment—it provides probabilities that doctors must then interpret and investigate further.

Heart failure is classified into four stages. Stage A involves patients with risk factors like high blood pressure, diabetes, and elevated cholesterol but without structural heart damage. Stage B includes patients with heart changes but no symptoms—a critical window for early intervention. Stage C is when symptoms become apparent, while Stage D represents advanced failure requiring mechanical support or transplantation. Dr. Nicolau noted that patients often dismiss breathlessness and fatigue as normal aging, potentially delaying treatment. Women remain particularly vulnerable to under-diagnosis because their symptoms may present differently from those traditionally associated with heart disease in men.

Treatment approaches have evolved significantly beyond symptom management. Modern therapies including beta blockers, ACE inhibitors, aldosterone antagonists, and SGLT2 inhibitors target the biological processes driving heart failure progression. Some patients experience substantial improvement in their heart’s pumping ability, with ejection fractions improving from 20 percent to 40 or 50 percent, while others recover to normal levels. Even when heart function does not fully recover, appropriate treatment can improve quality of life and extend survival.

Heart failure affects millions globally and is often diagnosed only after symptoms become severe. The condition develops when the heart cannot pump sufficient blood to meet the body’s needs, triggering hormonal responses that can damage the organ further. Early detection and personalized treatment approaches are increasingly recognized as crucial to improving outcomes.

Heart disease remains a leading cause of mortality in Caribbean nations, where risk factors such as hypertension, diabetes, and obesity are prevalent. Dr. Nicolau’s emphasis on early detection and the role of AI-enhanced diagnostics is particularly relevant to Caribbean healthcare systems seeking to improve cardiac care and reduce preventable deaths among their populations.

Sources and attribution

CVCA Express Draft: verification pending; WordPress publication is manual.

Share This News Update

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top